These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19691457)

  • 41. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A].
    Zhao Y; Meng Z; Guo J; Wang X; Duo C; Liu H; Yao J; Chai S; Zhu H; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.
    Rosner G; Lurie Y; Blendis L; Halpern Z; Oren R
    Postgrad Med J; 2006 Mar; 82(965):207-10. PubMed ID: 16517803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis A: disease burden and current childhood vaccination strategies in the United States.
    Koslap-Petraco MB; Shub M; Judelsohn R
    J Pediatr Health Care; 2008; 22(1):3-11. PubMed ID: 18174084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
    Estripeaut D; Contreras R; Tinajeros O; Castrejón MM; Shafi F; Ortega-Barria E; DeAntonio R
    Vaccine; 2015 Jun; 33(28):3200-7. PubMed ID: 25981490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis A vaccination coverage among U.S. children aged 12-23 months - immunization information system sentinel sites, 2006-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(25):776-9. PubMed ID: 20592688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme.
    Godoy P; Carmona G; Manzanares S; Jane M; Borràs E; Camps N; Álvarez J; Barrabeig I; Sala MR; Rius C; Minguell S; Carol M; Ferras J; Domínguez A;
    J Viral Hepat; 2018 Sep; 25(9):1001-1007. PubMed ID: 29603832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatitis A in Poland in the years 2006-2007].
    Baumann A
    Przegl Epidemiol; 2009; 63(2):241-4. PubMed ID: 19799253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies.
    Victor JC; Surdina TY; Suleimenova SZ; Favorov MO; Bell BP; Monto AS
    Am J Epidemiol; 2006 Feb; 163(3):204-10. PubMed ID: 16339053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis vaccination and infection among gay, bisexual, and other men who have sex with men who attend gyms in New York City.
    Siconolfi DE; Halkitis PN; Rogers ME
    Am J Mens Health; 2009 Jun; 3(2):141-9. PubMed ID: 19477727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
    Li X; Xu Z; Hofman A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):93-6. PubMed ID: 10322718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis A in Australia in the 1990s: future directions in surveillance and control.
    Amin J; Heath T; Morrell S
    Commun Dis Intell; 1999 May; 23(5):113-20. PubMed ID: 10429311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
    Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y
    Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis A vaccination coverage among children aged 24-35 months--United States, 2004-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):678-81. PubMed ID: 17625495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination.
    Chen HL; Chang CJ; Kong MS; Huang FC; Lee HC; Lin CC; Liu CC; Lee IH; Wu TC; Wu SF; Ni YH; Hsu HY; Chen DS; Chang MH
    Hepatology; 2004 Jan; 39(1):58-63. PubMed ID: 14752823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis A virus infections in travelers, 1988-2004.
    Mutsch M; Spicher VM; Gut C; Steffen R
    Clin Infect Dis; 2006 Feb; 42(4):490-7. PubMed ID: 16421793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatitis A in 1998].
    Sitarska-Gołebiowska J; Jończyk M
    Przegl Epidemiol; 2000; 54(1-2):143-50. PubMed ID: 11076156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?
    Martinelli D; Bitetto I; Tafuri S; Lopalco PL; Mininni RM; Prato R
    Vaccine; 2010 Sep; 28(41):6783-8. PubMed ID: 20688041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis a vaccination coverage among children aged 24-35 months--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(6):141-4. PubMed ID: 15716804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.